title: Participant preferences for the provision of registration trials results.
abstract: BACKGROUND
  Clinical trials leading to drug approval (registration trials) play a central role in the drug development process, and attention has recently been paid to providing trial results to participants. In the present study, we examined the preferences of participants of registration trials for the provision of trial-related information.
  
  
  METHODS
  We used questionnaires to survey the preferences of registration trial participants at Tokushima University Hospital and Tokushima National Hospital. Of the 15 questions, 6 related to participant characteristics and the trials in which they participated, while 9 questions were concerned with preferences for the provision of information. A five-point scale (strongly agree, agree, neutral, disagree, and strongly disagree) was used, and positive answers (strongly agree and agree) were considered to indicate a positive preference.
  
  
  RESULTS
  Of the 58 subjects, 1 declined, giving a response rate of 98%. More than 70% of participants preferred to obtain information, even if they had served as controls. More than 80% of participants agreed to obtain information relating to trial results, even if the results were negative, and more than 80% of participants agreed to obtain information on the labeling state of the agent, even if development had ceased. Although more than 60% of participants agreed for the provision of information on their allocation and around more than 70% agreed to the provision of information on registration trials status, significantly fewer participants with difficult-to-treat diseases (for example, neurological and malignant diseases) agreed to obtain information compared with participants with other types of diseases (for example, acute, chronic, and psychological diseases). More than 50% of participants desired information to be provided directly by the physician, while a considerable number of participants desired information by means of clinical research coordinators (CRCs) (24.4%) or by posted letter (33.3%).
  
  
  CONCLUSIONS
  The present results suggest the preferences for the provision of individual and overall information concerning research results. However, further study is warranted to determine participant preferences more precisely and the effect of the CRC-initiated infrastructure for providing information on patient satisfaction and for promoting registration trials.
authors: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Japan.
authors: Soichiro
authors: S
authors: Tajima
authors: Akiyo
authors: A
authors: Akaishi
authors: Toshiko
authors: T
authors: Miyamoto
authors: Rumi
authors: R
authors: Katashima
authors: Kenichi
authors: K
authors: Nakai
authors: Takao
authors: T
authors: Mitsui
authors: Hiroaki
authors: H
authors: Yanagawa
keywords: Disclosure; Participants; Preference; Registration trials; Results
references: BMJ. 2002 Dec 7;325(7376):1329
references: 12468480
references: Lancet. 2001 Nov 24;358(9295):1772-7
references: 11734235
references: Br J Cancer. 2008 Jan 15;98(1):34-8
references: 18059398
references: J Med Ethics. 2007 Sep;33(9):549-53
references: 17761827
references: Trials. 2011 Jun 14;12:148
references: 21672204
references: BMJ. 2006 Jan 28;332(7535):206-10
references: 16401631
references: BMJ. 2006 Mar 4;332(7540):549-50
references: 16513719
references: Control Clin Trials. 1993 Dec;14(6):500-10
references: 8119065
references: J Clin Oncol. 2004 Nov 1;22(21):4312-8
references: 15514372
references: Int Arch Med. 2010 Jun 04;3:7
references: 20525325
references: Clin Trials. 2005;2(3):254-9
references: 16279148
references: PLoS Med. 2008 May 13;5(5):e91
references: 18479180
references: Trials. 2010 Dec 01;11:116
references: 21122094
references: Lancet. 2005 Mar 12-18;365(9463):963-4
references: 15766998